Diseases related to deficient GABAergic neurotransmission, such as epilepsy, depression, Alzheimer´s disease and anxiety disorders, respresent a major world health issue, hence requiring effective and tolerable medication. In this context, the GABA transporter subtype mGAT4 has come into focus as p...